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Abstract
Background: One important concept in traditional Chinese medicine (TCM) is
“treating different diseases with the same therapy”. In TCM practice, some patients
with Rheumatoid Arthritis (RA) and some other patients with Coronary Heart Disease
(CHD) can be treated with similar therapies. This suggests that there might be
something commonly existed between RA and CHD, for example, biological
networks or biological basis. As the amount of biomedical data in leading databases
(i.e., PubMed, SinoMed, etc.) is growing at an exponential rate, it might be possible
to get something interesting and meaningful through the techniques developed in
data mining.
Results: Based on the large data sets of Western medicine literature (PubMed) and
traditional Chinese medicine literature (SinoMed), by applying data slicing algorithm
in text mining, we retrieved some simple and meaningful networks. The Chinese
herbs used in treatment of both RA and CHD, might affect the commonly existed
networks between RA and CHD. This might support the TCM concept of treating
different diseases with the same therapy.
Conclusions: First, the data mining results might show the positive answer that
there are biological basis/networks commonly existed in both RA and CHD. Second,
there are basic Chinese herbs used in the treatment of both RA and CHD. Third,
these commonly existed networks might be affected by the basic Chinese herbs.
Forth, discrete derivative, the data slicing algorithm is feasible in mining out useful
data from literature of PubMed and SinoMed.
Background
Traditional Chinese Medicine (TCM), is one of China’s splendid cultural heritages [1,2]
with various intelligent theoretical thinking. One important concept in TCM is called
“Treating Different Diseases with the Same Therapy” (TDDST), which can be
explained as that different diseases might be shown with similar TCM patterns based
on TCM diagnostic information (such as symptoms, pulse feelings and tongue appear-
ance). Therefore, they could be treated with similar therapies in TCM. For example, in
Western medicine, Rheumatoid Arthritis (RA) and Coronary Heart Disease (CHD) are
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However, in TCM pattern classification, they share similar TCM patterns during their
development. RA and CHD, named as Impediment Pattern (Bi Zheng) and Palpita-
tions/Angina Pectoris (Xin Ji/Xin Tong) respectively in TCM, could show similar TCM
patterns in Qi deficiency and blood stasis based TCM pattern classification [2], thus
the two diseases can be treated with similar therapy in this case (reinforcing the defi-
cient Qi and dissolving the blood stasis), which has been practiced during the long-
term TCM activities [2].
The successful clinical practise of TDDST in TCM may suggest the fact that there
may be similar (or same) biological networks/basis in RA and CHD. Due to the com-
plexity of biological networks/basis, the common features are impossible to be revealed
by single experiment or research. Thus, they keep concealed hitherto. It can be sup-
posed that some potential regularity might be discovered by integrated analysis of the
global literatures on the two diseases, in both English and Chinese.
Although forming different theoretical systems, both TCM and Western Medicine
are aiming at human health services. Thus the interdisciplinary research might lighten
the cognition of health and diseases. Based on this, we retrieved data from both
PubMed and SinoMed. In analyzing data from PubMed, we can calculate the biological
networks/basis on Western Medicine commonly existed in both RA and CHD. From
SinoMed, we can filter out the basic Chinese herbs used for the treatment of both RA
and CHD. Therefore, we try to find out some common regularities between RA and
CHD through the overall literatures in both PubMed (English literature) and SinoMed
(TCM literature) by data mining technique. Progress in digital data acquisition and
storage technology has resulted in the growth of huge databases. Thus, it is impossible
for anyone to read them line by line, or record by record. Based on this, we turn to
the technique of data mining. Data mining is the analysis of (often large) observational
data sets to find unsuspected relationships and to summarize the data in novel ways
that are both understandable and meaningful/useful to the data owner and users
[3-12]. During the process of data mining, we explored databases of PubMed for Eng-
lish literature and SinoMed for TCM literature in Chinese.
Results and Discussion
After data mining, we got some well-structured networks, i.e., wheel-shaped, wheel-
wheel shaped, and wheels-connected shaped, etc. What’s more, these networks are not
only in good shapes, they might also demonstrate something meaningful in researches.
Wheel-shaped Networks
In Figure 1. The network visualized in this graph shows those pairs of Descriptor-
Names/keywords associated with central item “Inflammation”. It is clear that factors
associated with inflammation are far more than those listed in this graph, in either RA
or CHD. However, after associating together keywords of “Rheumatoid Arthritis” and
“Coronary Heart Disease”, on the frequency of “19”, only these keywords in Figure 1
are left.
To be more precise, take “Interleukin” confined within rectangles for example. If only
for RA, besides interleukin-1, 6, and 10, we can retrieve interleukin-2, 5, 7, 8, 11, 12,
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there are interleukins of interleukin-2, 8, and 18 are concerned.
At the first glance, one may wonder that why interleukin-2, 8, and 18 are not cov-
ered by the intersection of CHD and RA. The reason is: for DescriptorNames in
CHD_RA, things under considerations are the co-occurrent both in CHD and RA.
Interleukin-2, 8, and 18 do exist in data sets of CHD and RA. However, there is no co-
occurrent DescriptorName pairs link them into each other on frequency “19”.W h a t ’s
more, under the framework of TDDST in TCM theory, networks of this kinds or alike
can suggest something new for the research both on treatment and pathogenesis of
CHD and RA.
That is to say, through the calculation of data mining, we can get something which
might be useful for further research on the treatment and pathogenesis of CHD and
RA.
Apart from “Interleukin”, there are nodes tagged with “Cell Division”, “Apoptosis”,
“Acute Disease”, “Biological Markers” that are connected with center node “Inflamma-
tion”. They are all important concepts in systems biology. However, tags of “Cell Divi-
sion”, “Biological Markers”,a n d“Acute Disease” are not meaning too much concerned
with both RA and CHD, while “Apoptosis” and “Inflammation” a r em o r em e a n i n g f u l
to them. Things demonstrated in Figure 1 can also be shown in Figure 2.
In Figure 2., among all the nodes connected with center node “Apoptosis”,t h e yc a n
be grouped into two classes. One group is those nodes confined by rectangles. These
Figure 1 Wheel Shaped Network on Frequency 19. This network is constructed with data set
downloaded from PubMed on May 9, 2010. It is built under the condition that any two nodes connected
with each other by an edge are DescriptorName pairs on the co-occurrent frequency of “19”.
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meaningful in practice. The other group is those common nodes, tags of them are
much more abstract. Each of them indicates a concept of a biological process, or a set
of chemical material. Nodes within this group indicate knowledge in a much more
abstract way, usually, they just indicate common sense.
Wheel-wheel Shaped Networks
Upper part in Figure 3, we can see that two wheel-shaped networks connected with
each other by some commonly existed nodes.
In the left wheel, nodes around the center node tagged “Leukocytes” are all tagged
with abstract concepts, i.e., “Blood Platelets”, “Cell Migration Inhibition”, “Cell Adhe-
sion”, “Cell Movement”, and so on. As they cannot indicate much meaningful informa-
tion, they are taken as noises and ignored.
In the right wheel, apart from abstract concepts (i.e., “Biological Markers”, “Mast
Cells”, and “T-Lymphodytes”), we have “Interleukin"-1, 6, and 8, “Tumor Necrosis Fac-
tor - alpha”, and “C-Reactive Protein” connected with center node with tag “Inflamma-
tion Mediators”.
There is one interesting thing in this figure: an intersection composed of five nodes
between two wheel-shaped networks centered by “Leukocytes” and “Inflammation
Mediators”. The intersection nodes are “Cell Adhesion Molecules”, “Inflammation”,
Figure 2 Wheel-shaped Network on Frequency 22. This network is constructed with data set
downloaded from PubMed on May 9, 2010. It is built under the condition that any two nodes connected
with each other by an edge are DescriptorName pairs on the co-occurrent frequency of “22”.
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and the two centered nodes within wheel-shaped networks can also form a network.
This network can be dug out from the inter-connected wheel-shaped network, which
can is shown in lower part in Figure 3.
There are two interesting thing in this sub-network in Figure 3. One is the meaning
of this sub-network which has been described above. The other is that we can get a
third sub-network out from a network of two interconnected wheel-shaped networks.
Thus, we know that wheel-wheel shaped networks contain more information than
single-wheel shaped network. They can also suggest much more in medical research.
Wheels-connected Shaped Networks
In Figure 4. There are three wheel-shaped networks connected with each other. Thus,
they form one complex network.
This figure can tell us one important principle: all complex networks can be taken as
inter-connection of single wheel-shaped networks. Of course, there might be some
sub-networks which are isolated, and have no connections with others.
Figure 3 Wheel-wheel Shaped Network on Frequency 14 and It’sS u b _ n e t w o r k .T h i sn e t w o r ki s
constructed with data set downloaded from PubMed on May 9, 2010. It is built under the condition that
any two nodes connected with each other by an edge are DescriptorName pairs on the co-occurrent
frequency of “14”. The upper network in this figure is the whole network, while the lower network is a sub-
network which is composed of all nodes connecting two center nodes of “Leukocytes” and “Inflammation
Mediators”.
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are centered by “Phenotype”, “Membrane Glycoproteins”,a n d“Genetic Predisposition
to Disease” respectively. One type is those nodes connects two wheel-shaped networks,
i.e., “Biological Markers” connects wheels centered by “Phenotype” and “Membrane
Glycoproteins”, “Tumor Necrosis Factor-alpha” and “Carrier Proteins” connect wheels
centered by “Membrane Glycoproteins” and “Genetic Predisposition to Disease”.
“Mutation”, “Base Sequence”, “Linkage (Genetics)”, “Haplotypes”,a n d“Genetic Mar-
kers” connect wheels centered by “Phenotype” and “Genetic Predisposition to Disease”.
The other type is those who connect all the three wheel-shaped networks. For exam-
ple, nodes with tag “Gene Frequency” and “Genotype” confined within a red rectangle,
each of them has three edges out to the three wheel-shaped networks. Apart from the
two types of inter-connecting nodes, there are also meaningful nodes tagged with sin-
gle chemical materials. Each of them is confined within a rectangle, i.e., “Toll-Like
Receptor 4”, “CD40 Ligand”, “Fas Ligand Protein”, and “Tumor Necrosis Factor-alpha”.
Overview of These Networks in Systems Biology
From Figure 1, 2, 3, and 4, we can find that the pathogenesis of RA and CHD are
commonly associated with “inflammation”, “apoptosis”, “cytokines” and “macrophage”
et., which also have been verified by some experimental research [13-15].
Take “inflammation” in Figure 1 for example. In the past decade, many studies
reported that inflammation was the key pathogenesis in both RA and CHD [16,17].
Some immune cells and molecules such as macrophages, neutrophils, monocytes,
Figure 4 Wheels-connected Shaped Network on Frequency 16. This network is constructed with data
set downloaded from PubMed on May 9, 2010. It is built under the condition that any two nodes
connected with each other by an edge are DescriptorName pairs on the co-occurrent frequency of “16”.
Zheng et al. BioData Mining 2011, 4:18
http://www.biodatamining.org/content/4/1/18
Page 6 of 21cytokines and so on were all involved in the occurrence and development of these two
diseases. The abundance and activation of macrophages in the inflamed synovial mem-
brane/pannus significantly correlated with the severity of RA [14]. Reactive oxygen,
free radicals and lipase produced by macrophges played an important role in the devel-
opment of CHD [18-20]. High levels of Interleukin-1 (IL-1), Interleukin-6 (IL-6), Inter-
leukin-10 (IL-10) and Tumor necrosis factor-a (TNF-a) in the serum were observed in
RA and CHD patients [21-23]. In Figure 1, we can also find these useful information,
such as “macrophage”, “neutrophils”, “monocytes”, “IL-1”, “IL-6”, “IL-10” and “TNF-a“
etc. Therefore, these data demonstrate that our method to search the commonly
existed biological basis/pathogenesis between RA and CHD is feasible.
Cross Query between SinoMed and PubMed
We query the keywords of “Rheumatoid Arthritis” and “Coronary heart disease” in the
database of SinoMed. Several mostly used Chinese herbs for treating both of these two
diseases are found. They are Angelica, Salvia, Safflower and Astragalus which can be
found in Figure 5. In TCM theory, Chinese medicines of Salvia, Safflower, and Angel-
ica can be used to treat the pattern/syndrome of blood stasis, and Astragalus can be
used to treat the pattern/syndrome of Qi deficiency. What’s more, in TCM practise,
Figure 5 Network of basic Chinese herbs used in the treatment of RA and CHD.T h i sn e t w o r ki s
constructed with data set downloaded from SinoMed on Aug. 24, 2010. First, a list of Chinese herbs pairs
is built under the condition that any two nodes connected with each other by an edge are
DescriptorName pairs on co-occurrent frequency. Then, supervised by TCM professionals, four basic
Chinese herbs are selected out. Based on the four Chinese herbs, we mining them again in the data set of
SinoMed, and construct this network based on the co-occurrent frequency greater equal than “4”.
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inals, two medicinals used in pair can increase the therapeutic effect and reduce the
toxic effect [24]. For example, Angelica and Salvia is more powerful in reinforcing the
blood, Angelica and Astragalus can reinforce both Qi and blood, Salvia and Safflower
can reinforce the blood stasis. [25].
Then, we sliced data retrieved from PubMed with Mesh terms of “Angelica”, “Salvia”,
“Safflower” and “Astragalus” by the method of discrete derivatives and got some mean-
ingful results shown in Table 1 and 2. Interestingly, some familiar nodes emerge again,
i.e., “inflammation”, “apoptosis”, “cytokines”, “leukocytes” and “macrophages” et al.
Take “apoptosis” for example. As we know, apoptosis is the process of programmed
cell death, which plays a pivotal role in tissue homoeostasis. Apoptosis disorders can
lead to some serious diseases such as RA and CHD [26,27], which is also demonstrated
in our study, as shown in Figure 2. We queried “Angelica”, “Salvia”, “Safflower” and
“Astragalus” in PubMed and find “apoptosis” again and some specific nodes such as
“Caspase 3”, “Caspases”, “Proto-Oncogene Proteins c-bcl-2”, “bcl-2-Associated × Pro-
tein”, “Tumor Suppressor Protein p53”, et al, which are related with apoptosis and pre-
v i o u s l ye m e r g e di nF i g u r e2 .T h e s ed a t ai n d i c a t et h a tt h em e c h a n i s mo ft h e s ef o u r
Table 1 Results of data mining on RA and CHD in PubMed and SinoMed with Chinese
herbs Angelica and Salvia
SinoMed PubMed
Chinese
Herb
Biology Basis Detailed Information
Angelica Inflammation Apoptosis Caspase 3, Caspases, bcl-2-Associated × Protein, Proto-Oncogene
Proteins c-bcl-2, Transforming Growth Factor beta1, CD40 Ligand,
Tumor Necrosis Factor-alpha, Tumor Suppressor Protein p53, Vascular
Endothelial Growth Factor A
Leukocytes Cyclooxygenase 1, Phospholipases A, Prostaglandin-Endoperoxide
Synthases
Monocytes Interleukin-8
Cytokines Fibroblast Growth Factor 2, Intercellular Adhesion Molecule-1,
Interleukin-2, Interleukin-6, NF-kappa B, Toll-Like Receptor 4,
Transforming Growth Factor beta, Transforming Growth Factor beta1
Macrophages Nitric Oxide Synthase Type II, Cyclooxygenase 2, Interleukin-2, NF-
kappa B, Nitric Oxide Syn-thase, Tumor Necrosis Factor-alpha,
Interleukin- 6, Cyclooxygenase 1, Interleukin-1, Prostaglandin-
Endoperoxide Synthases
Salvia Inflammation Apoptosis Caspase 3, Caspases, Proto-Oncogene Proteins c-bcl-2, bcl-2-
Associated × Protein, Tumor Suppressor Protein p53, L-Lactate
Dehydrogenase, Proto-Oncogene Proteins c-akt, Proto-Oncogene
Proteins, Tumor Necrosis Factor-alpha, Cyclooxygenase 2, Intercellular
Adhesion Molecule-1, Interleukin-2, Interleukin-6, Interleukin-8, Platelet-
Derived Growth Factor, Vascular Endothelial Growth Factor A
Leukocytes Intercellular Adhesion Molecule-1, Tumor Necrosis Factor-alpha
Monocytes Proto-Oncogene Proteins, Transforming Growth Factor beta1, Tumor
Necrosis Factor-alpha
Cytokines Alanine Transaminase, Tumor Necrosis Factor- alpha, Interleukin-6,
Interleukin-8, Nitric Oxide Synthase Type II, Platelet-Derived Growth
Factor, Prostaglandin- Endoperoxide Synthases, Transforming Growth
Factor beta1
Macrophages Nitric Oxide Synthase Type II, Tumor Necro-sis Factor-alpha,
Cyclooxygenase 2, NF-kappa B, Interleukin-1, Interleukin-6, Nitric Oxide
Synthase, Transforming Growth Factor beta1, Caspases, Chemokine
CCL2, E-Selectin, Intercellular Adhesion Molecule-1, Matrix
Metalloproteinase 9
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lating apoptosis-related signal pathway, which are consistent with some experimental
results [28,29].
In sum, from the Table 1 and 2, we can obtain following useful information:
1. For the treatment of RA and CHD, some basic Chinese herbal medicines are
used. They are Angelica, Salvia, Safflower and Astragalus. In TCM theory, Chinese
herbs of Angelica, Salvia and Safflower can be grouped into the class of reinforcing
blood, while Astragalus can be grouped into the class of reinforcing Qi;
2. The mechanisms of these commonly used traditional Chinese herbal medicines
for the treatment of both RA and CHD are mostly associated with “inflammation”,
“apoptosis”, “cytokines”, “monocytes”, “macrophages”,e t c . ,w h i c hi n d i c a t et h a t
these herbs can affect the same biological networks that are commonly existed in
RA and CHD;
3. Data mining results demonstrate that our method is feasible, and they may sup-
port the concept of TDDST in TCM;
4. These results can also give us some useful tips for the future research of these
two diseases.
Table 2 Results of data mining on RA and CHD in PubMed and SinoMed with Chinese
herbs Safflower and Astragalus
SinoMed PubMed
Chinese
Herb
Biology Basis Detailed Information
Safflower Inflammation Apoptosis Proto-Oncogene Proteins c-bcl-2, Caspase 3, bcl-2- Associated ×
Protein, Caspases, Nitric Oxide Synthase, Prostaglandin-Endoperoxide
Synthases, Vascular Endothelial Growth Factors
Leukocytes Interleukin-2, Leukotriene B4, Linoleic Acid, Throm-boxane B2,
Triglycerides
Monocytes Interleukin-1, Tumor Necrosis Factor-alpha, Interleukin-6, NF-kappa B,
Intercellular Adhesion Molecule-1
Cytokines Interleukin-6, Tumor Necrosis Factor-alpha, Interleukin-1, Interleukin-
10, Thromboxane B2, 6-Ketoprostaglandin F1 alpha, Cyclooxygenase
1, Cyclooxygenase 2, Leukotriene B4, NF-kappa B, Prostaglandin-
Endoperoxide Synthases, Toll-Like Receptor 4
Macrophages Eicosapentaenoic Acid, Interleukin-2, Prostaglandins E, Tumor
Necrosis Factor-alpha, Interleukin-1, Leukotriene B4, Endothelial
Growth Factors, Prostaglandin-Endoperoxide Synthases, Thromboxane
B2, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth
Factors
Astragalus Inflammation Apoptosis Caspase 3, Tumor Necrosis Factor-alpha, Caspases, NF-kappa B, Proto-
Oncogene Proteins c-bcl-2, bcl-2-Associated × Protein, Interleukin-10,
Interleukin-6, Nitric Oxide Synthase Type II, Transforming Growth
Factor beta1, Tumor Suppressor Protein p53
Leukocytes Cyclooxygenase 1, E-Selectin, Intercellular Adhesion Molecule-1, NF-
kappa B, Phospholipases A, Tumor Necrosis Factor-alpha
Monocytes Tumor Necrosis Factor-alpha
Cytokines Interleukin-2, Interleukin-10, Interleukin-6, Interleukin-1, Interleukin-8,
Matrix Metalloproteinase 9, Toll-Like Receptor 4, Transforming Growth
Factor beta1, Tumor Necrosis Factor-alpha, Vascular Endothelial
Growth Factor A
Macrophages Interleukin-1, Interleukin-2, NF-kappa B, Toll-Like Receptor 4
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First, common biological networks/basis may exist
Through the calculation, we get partial resu l t ss h o w ni nF i g u r e1 ,2 ,3 ,a n d4 .T h e s e
figures indicate the existence of common biological networks and biological basis in
both RA and CHD;
Second, basic Chinese herbal medicines may affect these common biological networks/
basis
Through the calculation of derivatives on different orders (i.e., primary, secondary, etc.)
between PubMed and SinoMed, back and forth, we get the data that support the TCM
concept of TDDST through data mining. In brief, the biological basis/networks com-
monly existed in RA and CHD, and they might be affected by the Chinese herbal med-
icines which are used in TCM therapies for both RA and CHD;
Third, our data slicing algorithm works
Through the above two items, we have reason to believe that our data slicing algo-
rithm, together with other skills adopted in data mining, can dig out simple and mean-
ingful information from large data sets from both PubMed and SinoMed. What’s
more, these results may support the concept of TDDST in TCM.
Methods
For data mining, data preparation, pretreatment, and treatment is fundamental and
necessary [30-33] for the final result.
The whole process of data mining is scheduled as described below. First, mine the
data retrieved from Pubmed. Through this process, we get the common biological net-
works/basis existing in both RA and CHD. Then, mine the data retrieved from
SinoMed. By doing this, we get the basic Chinese herbal medicines (with the highest
frequencies occurring in literature) which are used for the treatment of both RA and
CHD. At last, we turn to PubMed again with the basic Chinese herbal medicines for
verification. After analyzing the data retrieved from PubMed with these basic Chinese
herbs, we will verify our hypothesis: these basic Chinese herbs might affect those biologi-
cal networks/basis commonly existed in both RA and CHD.I nb r i e f ,w ec a nt e s t
whether or not these Chinese herbs used against RA and CHD in TCM can affect the
biological networks/basis existed in both RA and CHD.
Data from PubMed and SinoMed
PubMed is a free database accessing the MEDLINE database of citations, abstracts and
some full text articles on life sciences and biomedical topics. The United States
National Library of Medicine (NLM) at the National Institutes of Health (NIH) main-
t a i n sP u b M e da sp a r to ft h eE n t r e zi n f o r m a t ion retrieval system [34]. We retrieved
data of RA and CHD from PubMed as basic material for data mining. SinoMed http://
sinomed.cintcm.ac.cn/index.jsp is also a database like PubMed. The characteristic of
SinoMed is that this database focus on Chinese literature in the fields of TCM, biologi-
cal and medicine. We only retrieve TCM data in SinoMed for basic Chinese herbs
used for the treatment of both RA and CHD.
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As mentioned above, we queried the keywords of “Rheumatoid Arthritis” and “Coron-
ary Heart Disease” in the database of PubMed http://www.ncbi.nlm.nih.gov/pubmed/
on May 9, 2010. To be more specific, we searched MeSH for “Rheumatoid Arthritis”
[MeSH Major Topic] with Restrict Search to Major Topic headings only retrieved a
record set of 67,049 papers. Search MeSH for “Coronary Heart Disease” [MeSH Major
Topic] with Restrict Search to Major Topic headings only retrieved records of 115,757.
When this query was done, we downloaded these retrieved data sets in the type of
XML into local computer system for the pretreatment.
In SinoMed http://sinomed.imicams.ac.cn/index.jsp, we queried the MeSH terms of
“Rheumatoid” and “Arthritis” for RA, “Coronary Heart Disease” for CHD in Chinese
on Aug. 24, 2010. By querying terms of “Default: Coronary Heart Disease or Rheuma-
toid or Arthritis“ in Chinese, we retrieved 60,967 records for CHD, and 13,686 records
for RA. The difference between PubMed and SinoMed is that PubMed can download
all data in one time, while in SinoMed, we can only download 500 record one time.
Pretreat Data
After retrieving data from PubMed (the same with SinoMed), we listed the data order
by PMID and found that, for each PMID, there were several DescriptorNames asso-
ciated with it. What’s more, these DescriptorNames are also the keywords of this
paper. Observed this, it is natural and intuitive to construct pairs of co-occurrent
DescriptorNames from the retrieved data [35]. When the tables of co-occurrent
DescriptorName pairs are constructed, it is natural to calculate the frequencies of
these pairs [8,36,37]. When the tables of frequency pairs are built, our data slicing
algorithm get its input raw material.
In order to analyze these data retrieved from PubMed and SinoMed by these given
keywords, the best way is to get interesting data into the framework of structured file
system, i.e., structured databases [5,7,9,38]. Because only in the structured database,
large amount of optimization techniques can be applied and taking effects. Then, we
can get efficient processing of our algorithm on large data sets [5].
For PubMed data sets, we transferred the XML data to the structured database of
Microsoft
® SQL
® 2000. In order to find new pattern and rules in data mining and text
mining, we should understand our data first. The more we understand our data (espe-
cially with specified knowledge), the more accurately and efficiently we can do in
further analysis [38]. For SinoMed data sets, we developed a tool to transfer its plain
TXT data into Microsoft
® SQL
® 2000.
In structured database, we focused on the relationships among keywords (both
PubMed and SinoMed), i.e., PMID (paper ID in PubMed database) and Descriptor-
Name (keywords associated with PMID in PubMed database). For example, we have
data: <PMID> = ‘20464912’, and <DescriptorName> = {physiopathology, rehabilitation,
Evidence-Based Medicine, Humans, Muscle Stretching Exercises, Physical Fitness,
Resistance Training, Treatment Outcome}. For the convenience of data processing, the
set of DescriptorName is listed in Table 3.
Then, based on the assumption that the keywords’ frequency can represent the
research interests world wide, and potential causal connection, we construct the algo-
rithm which is show in Table 4. This algorithm constructs the co-existing
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the table of co-occurrent DescriptorName pairs in Table 5.
By the algorithm in Table 4 we can build the table of co-occurrent DescriptorName
pairs. By applying this algorithm with input of Table 3 we can get the result demon-
strated in Table 5.
Based on Table 5 our algorithm of discrete derivatives on the distribution frequency
can get its turn for calculations.
Design Algorithm to Treat Data Sets
In the process of data mining, we construct an data slicing algorithm called discrete
derivatives. This algorithm is based on the calculation of frequency. First, it splits data
into different “layers”, i.e., slicing actions are executed based on the frequency distribu-
tion of DescriptorName pairs. When data slices are calculated, we construct the func-
tion of discrete derivatives fdd. This is based on the principle of derivative in advanced
calculus [39] yet in discrete space. Function fdd can calculate the difference between
two adjacent data slices. When discrete derivatives fdd are calculated, we will discuss
one property of function fdd.
PubMed Data
Among the tables of co-occurrent DescriptorName pairs in CHD, RA and CHD_RA
(intersection of CHD and RA), there might be something interesting existed. In the
Table 3 A Paper in PubMed with Its PMID and DescriptorNames
PMID DescriptorName
20464912 physiopathology
20464912 rehabilitation
20464912 Evidence-Based Medicine
20464912 Humans
20464912 Muscle Stretching Exercises
20464912 Physical Fitness
20464912 Resistance Training
20464912 Treatment Outcome
Table 4 Algorithm of Calculating Co-occurrent DescriptorNames
USE Table I
FOR each P MID
k = Number_of_DescriptorName(PMID)
j =1
FOR DescriptorNames(i)( i =, 1, 2,..., k)
DO while j ≤ k
DescriptorNames Pair = DescriptorNames(i)+
DescriptorNames (j)
j = j +1
OUTPUT DescriptorName_Pair INTO
table DM_pairs
ENDDO
j =1
ENDFOR
ENDFOR
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there are 1,474 lines. That is, focused on the DescriptorName pairs within both RA
and CHD, there are only 1,474 pairs left. Table CHD_RA forms the initial data of un-
directed graph on the DescriptorName.
Table 5 Results of Co-occurrent DescriptorName Pairs Calculated by Algorithm in Table
3 with Raw Data Listed in Table 2
DescriptorName_1 DescriptorName_2
physiopathology rehabilitation
physiopathology Evidence-Based Medicine
physiopathology Humans
physiopathology Muscle Stretching Exercises
physiopathology Physical Fitness
physiopathology Resistance Training
physiopathology Treatment Outcome
rehabilitation Evidence-Based Medicine
rehabilitation Humans
rehabilitation Muscle Stretching Exercises
rehabilitation Physical Fitness
rehabilitation Resistance Training
rehabilitation Treatment Outcome
Evidence-Based Medicine Humans
Evidence-Based Medicine Muscle Stretching Exercises
Evidence-Based Medicine Physical Fitness
Evidence-Based Medicine Resistance Training
Evidence-Based Medicine Treatment Outcome
Humans Muscle Stretching Exercises
Humans Physical Fitness
Humans Resistance Training
Humans Treatment Outcome
Muscle Stretching Exercises Physical Fitness
Muscle Stretching Exercises Resistance Training
Muscle Stretching Exercises Treatment Outcome
Physical Fitness Resistance Training
Physical Fitness Treatment Outcome
Resistance Training Treatment Outcome
Table 6 Algorithm of Calculating Frequency of Co-occurrent DescriptorName Pairs
USE table CHD_RA
k = max_line_number
DO while k ≥ 1
GO top
FOR DescriptorName_Pair(1)//The 1st pairs in CHD_RA
COUNT its Frequency
EndFor
OUTPUT DescriptorName Pairs, Frequency INTO table
CHD_RA_Frqncy
DELETE all DescriptorName_Pair(1) from table
CHD_RA
k = max_line_number
ENDDO
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Page 13 of 21Based on the table of co-occurrent DescriptorName pairs of CHD_RA in Table 5 we
can further build the table of frequency distribution on it. This is done by the follow-
ing algorithm in Table 6.
When table CHD_RA_Frqncy is constructed, we can classify the data of co-occurrent
DescriptorName pairs into different slices according to their frequency distributions.
Thus, we get the table of data slices as CHD_RA_Frqncy _i where i = 1, 2, 3,···, 30
with 30 is the greatest frequency existed in table CHD_RA_Frqncy.
When this is done, we have the tables of data slices according to distributions of
DescriptorName_Pairs. However, though the data slices are much more simple in com-
plexity and small in size, we still cannot get useful data from those binary-relationship
tables. Based on this, we can get them visualized for better understanding through
visualization. By software Cytoscape, we can observe them in different graphs accord-
ing to their frequencies, which can be shown in Figure 6.
From Figure 6, we can see that there is a trend of simplification as frequency goes
from 1 to 30. For example, numbers within parentheses keep descending as frequency
increases.
What’s more, as frequency goes up from 1 to 18, the main part of these networks are
too complicate to check for naked eye. Then, it is hard for one to get useful informa-
tion on the first view. However, there are some notable “wheel” shape sub-networks of
existed in graphs on frequencies of 1, 2, 6, 8, 9, and 10. These wheel-shaped sub-net-
works might have some meaningful cue. As frequency goes from 19 to 24, some well
structured sub-networks can be observed in these graphs. For example, on frequencies
of 19, 20 and 21, there are distinct wheel-shape sub-networks in the left-top position
of the graphs. As frequency goes beyond 25, it is clear that we can get wonderful rela-
tionships among DescriptorNames.
Check graphs on different frequencies, we can get that, apart from the fact that most
of them are distinct, there are also some similar even equivalent graphs, i.e., 25 and 26.
Note: in Figure 6, for better visual effects, keeping topology structure unchanged, we
re-arranged the nodes in graphs on frequencies 24 and 25 by moving their positions
for better view angle. For example, move nodes from density areas to sparse areas, so
as to get better structured sub-networks. We also did this in Figure 7 on frequencies
numbered 9, 13, 14, 16, and 23.
Now, we can calculate the distribution of co-occurrent DescriptorNames pairs on
each distinct frequency. We call this distribution as level distribution, because it slices
original data set into different subsets according to the frequency distribution, and
these distributions are calculated from co-occurrent DescriptorNames pairs. Thus,
level distribution is the difference between two adjacent slices of initial data set. For-
mally, we have the following formal definition.
Definition 1 (Level Distribution) For given data set D,l e tk be the hierarchical para-
meter, where k is the maximum frequency of occurrence and k = max(frequency(ei)).
For slices of data sets slicei (i = 1, 2,···, k)i nD, level distribution ld can be expressed
by formula ldi = slicei - slicei+1 where i = 1, 2,···, k-1.
We calculate level distributions between different initial frequencies, i.e., top-left cell
in Figure 7 with subscription of “1(179)” means the visualized data of level distribution
“1”. “1” means the data slice ID, and it represent the data between initial data slices of
frequencies “1” and “2”. “179” in parentheses means the number of nodes
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Page 14 of 21(DescriptorName) represented in level distribution “1”. Figure 7 shows all level distri-
butions of frequencies, i.e., from “1” to “30”.
From Figure 8, we can see that the level distribution of initial data is much more
simple and meaningful.
Left-top graph above cell “1(179)” illuminates the data on frequency distribution of
“1”. There are large amount of connected pairs of co-occurrent DescriptorNames com-
posed of “2”, “3”, “4” or “5” nodes. These pairs can illuminate three kinds of
Figure 6 Graphics of initial data based on frequency with nodes in parenthesis. These networks are
constructed with data set downloaded from PubMed on May 9, 2010. They are built under the conditions
that any two nodes connected with each other by an edge are DescriptorName pairs on the co-occurrent
frequencies. These frequencies can be demonstrated as integer which are greater equal than i, where i =1 ,
2, 3,···, 30.
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1. Common knowledge already existed, useful but meaningless for research;
2. Rarely involved knowledge, can be taken as noises or false positive findings;
3. Emerging knowledge, useful and meaningful for research.
Graphs on frequencies “1” and “2” are both of this kind. As for graphs on frequen-
cies “3"-"8” and “15”, there is no specific structures exist. To get better understanding
of these data, we have to check these graphs manually. Graphs on frequencies “10"-
Figure 7 Graphics of data slices on level distribution based on frequency with nodes in
parenthesis. These networks are constructed with data set downloaded from PubMed on May 9, 2010.
They are built under the conditions that for a network on frequency i (i = 1, 2, 3,···, 30) which are in Fig. 7.
We calculate the data slice slicei with formula slicei - slicei+1 with i ≤ 29.
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Page 16 of 21"14”, “16” and “23”, are clearly structured on topology, nodes in these graphs indicate
explicit relationships among DescriptorNames. As for graphs on frequencies “18”, “19”,
“21”, “22”, “24”,a n d“26”, nodes inside them are wheel-shaped with a centered node,
all other nodes are around the centered one. These graphs indicate some knowledge to
a large probability of popular science in professional eyes. Graphs on frequencies “17”,
“20”, “25”,a n d“27"-"29” are blank, this means that there is no content in the level of
these frequencies. On “30”, as there is nothing exists higher than it but empty set ∂,
so, it is meaningless to calculate its content.
Figure 8 Graphics of the first discrete derivative based on frequency with nodes in parenthesis.
These networks are constructed with data set downloaded from PubMed on May 9, 2010. They are built
under the conditions that for a network on frequency i (i = 1, 2, 3,,···, 29) which are in Fig. 8. We calculate
the discrete derivative slice 
i =
slicei − slicei+1
1
= slicei − slicei+1 with i ≤ 28.
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Page 17 of 21As we have calculated level distribution as s h o w ni nF i g u r e7 ,i ti sn a t u r a lf o ru st o
t h i n ko fc a l c u l a t i n gt h ediscrete derivative of these level distributions for even more
simple results. The discrete derivative came from the principle of derivative in
advanced calculus [39], which means calculating the changing-rate/velocity of the data
in a continuous space. Formally, we have f 
x0 =
f(x) − f(x0)
x − x0
=
(y)
(x)
.
Based on this, we give out the formal definition of discrete derivative.
Definition 2 (Discrete Derivative) For a given serious of data slices slicei with i =1 ,
2,···, k where k is a natural number, discrete derivative is
ld  =
slicei − slicei+1
1
= slicei − slicei+1.
Definition 2 gives out the definition of the first order of discrete derivative on the
slices of initial data set. Enlightened by the calculation of higher order derivatives in
advanced calculus [39], we give out the definitions of higher order discrete derivatives.
Definition 3 (Higher Order of Discrete Derivative)
As ld’ = slicei - slicei+1 is the first order discrete derivative, and ld” =( ld”) is the sec-
ond discrete derivative. Then, higher order of discrete derivative is ld
(j) =( ld
(j-1))’
where j Î INT and j> 2.
In order to get the full view of the discrete derivatives, we calculate several orders of
derivative (i.e., the first order, the second order, etc.) based on Definition 2. Most of
them are similar and we show the first derivative in Figure 8.
Checking graphs in Figure 8, we can see that most of the graphs in Figure 8 are
exactly the same as Figure 7, except on frequency “29”. It is blanked by the definition
of the algorithm on discrete derivative. It is meaningless to calculate the derivative of
the last point, which is the same as frequency “30” in Figure 7. What’s more, we con-
tinue our test of calculating the second, the third, and even the forth discrete deriva-
tives, all these results demonstrate one interesting phenomenon: for a given frequency,
discrete derivatives all orders are constant. That is to say, discrete derivatives of given
frequency keep unchanged and independent of the orders of discrete derivative.
Now, take Figure 7 and 8 for example, it is very interesting that there are some slight
differences between them. For example, pairs on frequencies of “2”, “4”, “9”, “11”, “12”,
“13”,···. However, check them carefully, we can find that their nodes and edges are all
the same, this means their topology of nodes and relationships are all the same.
Then, naturally, comes another question. Why graphs within these two figures under
these frequencies are all the same? We all know that most derivative of functions
change in the continuous space [39], i.e., (x2)  =2 x,

3+x
3 − x
 
=
6
(3 − x)
2,a n ds oo n .
Of course, there are exceptions, i.e., c’ =0w h e r ec is constant, (e
x )’ = e
x and so on.
These phenomena are all have their own explanations. As to the reason of our ques-
tion, we believe that it is based on the essence of our data type: discrete characteristic
data in PubMed. If we have all the DescriptorNames assigned with specific numbers in
the continuous space, then, our discrete derivatives will have their numeric results.
What’s more, these results will change as those examples mentioned before.
Thus, we have our theorem of this interesting phenomenon.
Theorem 4 (Discrete Derivatives Keep Constant)
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Page 18 of 21Given a data set D with elements ei (i =1 ,2 , · · · ,n)w h e r e|D| = n is the size of the
data set. D can be made hierarchical by k where k = max (frequency(ei)), frequency(ei)
is the occur times of ei within D. Pairwise elements {ei, ej } stands for the co-occur-
rence within D where i ≠ j. Then, discrete derivatives ld
(m) = constant where m ≥ 1i s
the order of discrete derivative.
PROOF: By Definition 2, we know that the first order discrete derivative is
ld 
i = ldi − ldi+1
= (slicei − slicei+1) − (slicei+1 − slicei+2)
where 1 ≤ i ≤ k - 1, and let ld 
i = constanti.
By Definition 3, we have the second discrete derivative
ld  
i =( d 
i) 
=( ldi − ldi+1) 
=( ( slicei − slicei+1) − (slicei+1 − slicei+2))
− ((slicei+1 − slicei+2) − (slicei+2 − slicei+3))
By Definition 1, we have slicei = {ei|frequency(ei) =1 ,1≤ i ≤| D|}.W h a t ’sm o r e ,b y
algorithm in Table 4 we know that ei is distinct co-occurrent DescriptorName pair. By
algorithm in Table 6 we know that ei i =1 ,2 , · · · ,n are tagged with frequency frequency
(ei). Then, slicei is the collection of co-occurrent DescriptorName pairs with frequency
(ei)=1 .
Thus, we know that co-occurrent DescriptorName pairs of different frequency value
are also distinct. That is, ldi ∩ ldj = ∅ with i ≠ j. Then, we have ldi ∩ ldj+1 = ∅. Thus,
we have ldi - ldi+1 = ldi hold, which is also the first discrete derivative ld 
i.T ot h i s
point, we have an important result that ld 
i = ldi i =1 ,2 ,··· ,k − 1.N o w ,r e t u r nt ot h e
calculation of ld 
i and ld  
i, we have
ld 
i =( slicei − slicei+1) − (slicei+1 − slicei+2)
= slicei − slicei+1
= slicei
and
ld  
i =( ( slicei − slicei+1) − (slicei+1 − slicei+2))
− ((slicei+1 − slicei+2) − (slicei+2 − slicei+3))
=( slicei − slicei+1) − (slicei+1 − slicei+2)
= slicei − slicei+1
= slicei
Then, we have ld 
i = ld  
i.
In this way, we can prove that ld  
i = ld
(3)
i = ld
(4)
i = ···= ld
(k)
i .T o g e t h e rw i t hld 
i = ld  
i,
we have ld 
i = ld  
i = ld
(3)
i = ···= ld
(k)
i hold, and the proof is done.
SinoMed Data
In order to mine out the basic Chinese herbs used in the treatment of RA and CHD in
TCM, we turned to SinoMed for data sets. First, we calculated their commonly existed
DescriptorNames in the same way as described in PubMed. Then, we built a table of
Chinese herbs composed of 539 records as filter to filtrate the data retrieved from
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Page 19 of 21SinoMed. At last, we calculated the number of occurrences of Chinese herbs in the
data of SinoMed. When this was done, we checked the list with TCM professionals.
They found that the first four Chinese herbs listed at the top of number of occurrences
are reasonable. These four Chinese herbs are “Angelica”, “Salvia”, “Safflower” and
“Astragalus”. These four Chinese herbs can be found in Figure 5. By now, we ascertain
that these four Chinese herbs can be used to treat RA and CHD in TCM. However,
we still do not know whether or not they have association with the knowledge hidden
in PubMed which are studied by modern medical researchers. In order to verify our
idea that the Chinese herbs used in both RA and CHD can affect the biological net-
works/basic in both RA and CHD, we explore PubMed with these four Chinese herbs.
When these data set typed XML downloaded from PubMed, we transfer them into
Microsoft
® SQL
® 2000 as we did before.
Through the cross queries from SinoMed to PubMed with these four Chinese herbs
mentioned above, we get meaningful data in Table 1 and 2 which can support our
assumption that these basic Chinese herbs used to treat RA and CHD in TCM can
actually affect the biological networks/basis that exist in RA and CHD.
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